Halozyme Therapeutics Inc (HALO)

[stockrafter]

maumar........your comment is one of the reason I try not posting anything but the facts....Yes they were just "Patent Application Filings"......not granted.....No I do not have a handle on how long it will take to grant a patent for the recent HVAI "Patent Application Filings"......

Interestingly a "World Patent Application Filing" was also posted yesterday............this makes it easier to read the additional documentation......giving a lot more insight to the progress and additional information on the subject...........The original HVAI "Patent Application Filing" was actually made back in Dec 2022 as seen in some of the documents........so they have been working on it behind the scene for sometime......which suggest they are pushing it thru at a good rate......The reason why the.HVAI "Patent Application Filing" posting is a big deal at this point is that the filing must be posted to cover the intellectual property before any public clinical trial, and to help finalize deals with clients.

World patent application filing........ https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2024138188&_gid=202426

>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>

The link in first posting was a mistake..... I do not care about the rehash application filing........

Listed are filings of the same patent.......minor tweaks are made to an old patent and it is refiled....it is the main rhuph20 patent and they keep modifying it to keep it relevant....sorry to have made the mistake of posting the link and confusing matters...........

1. US20240209337 PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF
Modified PH20 hyaluronidase polypeptides, including modified polypeptides that exhibit increased stability and/or increased activity, are provided. Also provided are compositions and formulations...
2 12018298 PH20 polypeptide variants, formulations and uses thereof
Modified PH20 hyaluronidase polypeptides, including modified polypeptides that exhibit increased stability and/or increased activity, are provided. Also provided are compositions and formulations...
3 11952600 PH20 polypeptide variants, formulations and uses thereof
Modified PH20 hyaluronidase polypeptides, including modified polypeptides that exhibit increased stability and/or increased activity, are provided. Also provided are compositions and formulations...
4 US20240026328 PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF
Modified PH20 hyaluronidase polypeptides, including modified polypeptides that exhibit increased stability and/or increased activity, are provided. Also provided are compositions and formulations...
5 US20240026327 PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF
Modified PH20 hyaluronidase polypeptides, including modified polypeptides that exhibit increased stability and/or increased activity, are provided. Also provided are compositions and formulations...
6 US20240011008 PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF
Modified PH20 hyaluronidase polypeptides, including modified polypeptides that exhibit increased stability and/or increased activity, are provided. Also provided are compositions and formulations...
7 US20240002826 PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF
Modified PH20 hyaluronidase polypeptides, including modified polypeptides that exhibit increased stability and/or increased activity, are provided. Also provided are compositions and formulations...
8 US20240002825 PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF
Modified PH20 hyaluronidase polypeptides, including modified polypeptides that exhibit increased stability and/or increased activity, are provided. Also provided are compositions and formulations...
9 US20230357739 PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF
Modified PH20 hyaluronidase polypeptides, including modified polypeptides that exhibit increased stability and/or increased activity, are provided. Also provided are compositions and formulations...
10 US20230295593 PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF
Modified PH20 hyaluronidase polypeptides, including modified polypeptides that exhibit increased stability and/or increased activity, are provided. Also provided are compositions and formulations...
11 US20230295592 PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF
Modified PH20 hyaluronidase polypeptides, including modified polypeptides that exhibit increased stability and/or increased activity, are provided. Also provided are compositions and formulations...
12 US20230287381 PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF
Modified PH20 hyaluronidase polypeptides, including modified polypeptides that exhibit increased stability and/or increased activity, are provided. Also provided are compositions and formulations...
13 US20230250409 PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF
Modified PH20 hyaluronidase polypeptides, including modified polypeptides that exhibit increased stability and/or increased activity, are provided. Also provided are compositions and formulations...
14 US20230212547 PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF
Modified PH20 hyaluronidase polypeptides, including modified polypeptides that exhibit increased stability and/or increased activity, are provided. Also provided are compositions and formulations...
15 US20230151346 PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF
Modified PH20 hyaluronidase polypeptides, including modified polypeptides that exhibit increased stability and/or increased activity, are provided. Also provided are compositions and formulations...
16 US20210284985 PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF
Modified PH20 hyaluronidase polypeptides, including modified polypeptides that exhibit increased stability and/or increased activity, are provided. Also provided are compositions and formulations...
17 US20210277376 PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF
Modified PH20 hyaluronidase polypeptides, including modified polypeptides that exhibit increased stability and/or increased activity, are provided. Also provided are compositions and formulations...
18 11066656 PH20 polypeptide variants, formulations and uses thereof
Modified PH20 hyaluronidase polypeptides, including modified polypeptides that exhibit increased stability and/or increased activity, are provided. Also provided are compositions and formulations...
19 11041149 PH20 polypeptide variants, formulations and uses thereof
Modified PH20 hyaluronidase polypeptides, including modified polypeptides that exhibit increased stability and/or increased activity, are provided. Also provided are compositions and formulations...
20 10865400 PH20 polypeptide variants, formulations and uses thereof
Modified PH20 hyaluronidase polypeptides, including modified polypeptides that exhibit increased stability and/or increased activity, are provided. Also provided are compositions and formulations...
21 US20200318091 PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF
Modified PH20 hyaluronidase polypeptides, including modified polypeptides that exhibit increased stability and/or increased activity, are provided. Also provided are compositions and formulations...
22 US20200255814 PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF
Modified PH20 hyaluronidase polypeptides, including modified polypeptides that exhibit increased stability and/or increased activity, are provided. Also provided are compositions and formulations...
23 EP3130347B1 PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF